Leah Lackas, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Park St E, Annandale, MN 55302 Phone: 320-274-3737 |
Samantha Noetzelman Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Park St E, Annandale, MN 55302 Phone: 320-274-3737 |
Courtney Nicole Cahow, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Park St E, Annandale, MN 55302 Phone: 320-274-2591 |
Mrs. Margaret Bao Van Kor, OTR/L Occupational Therapist - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 500 Park St E, Annandale, MN 55302 Phone: 320-274-1470 |
Brooke Lange, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 209 Ash St E, Annandale, MN 55302 Phone: 320-274-1007 |
Andrea Brekken Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Park St E, Annandale, MN 55302 Phone: 320-274-3737 |
Roberta Peery, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Park St E, Annandale, MN 55302 Phone: 763-689-5385 |
Jessica Lea Kirchoff, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Park St E, Annandale, MN 55302 Phone: 320-274-3737 |
News Archive
AbilTo, Inc., a company that delivers proven behavioral health programs to help adults overcome mild and moderate depression associated with major medical events, announced today the completion of a $3 million round of Series A financing to fund the expansion of the Company's proprietary programs and technology platform.
As part of its ongoing work on biocompatibility and bioactivity of Hydroxyapatite (HA), Ceram, the materials technology company, has published a new white paper, ‘Multi-Substituted Hydroxyapatites and the Role They Can Play in Enhanced Bone Replacement Solutions'.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin approval for the treatment of symptomatic Vitreomacular Adhesion.
Dipexium Pharmaceuticals, Inc., a late-stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, topical antibiotic peptide, today announced operational, clinical and financial results for the year ended December 31, 2014.
› Verified 4 days ago